Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,046 public trials 569 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

NCT02165397

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Emory University Hospital Atlanta, Georgia, United States
View all 48 locations
View Trial Details
Completed

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

NCT01753453

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number 056002 Bruges, Belgium
  • Investigational Site Number 233001 Tallinn, Estonia
  • Investigational Site Number 440001 Vilnius, Lithuania
  • Investigational Site Number 752001 Stockholm, Sweden
View Trial Details
Completed

Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)

NCT01581593

Conditions
Agammaglobulinemia, Antibody Deficiency, Blood Protein Disorders, +11 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
  • Rush University Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis

NCT03506386

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centro de Hematologia e Oncologia (CEHON) Salvador, Estado de Bahia, Brazil
  • Hospital Sao Rafael Salvador, Estado de Bahia, Brazil
  • Hospital das Clinicas da UFG Goiânia, Goiás, Brazil
  • Hospital das Clinicas da UFMG Belo Horizonte, Minas Gerais, Brazil
View all 17 locations
View Trial Details
Completed

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03477643

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Hospital de Sant Joan de Déu Barcelona, Spain
  • Hospital Donostia-Donostia Ospitalea Donostia / San Sebastian, Spain
  • Hospital Universitario Virgen de Las Nieves Granada, Spain
  • Hospital General San Jorge - Huesca Huesca, Spain
View all 27 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions